Momentum Is Strong For Alector Inc (NASDAQ: ALEC)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Alector Announces Closing of Public Offering.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $6.11 and fluctuated between $6.28 as its day high and $5.86 as its day low. The current market capitalization of Alector Inc is $514.10M. A total of 0.63 million shares were traded on the day, compared to an average of 706.83K shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, ALEC has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 19 SELLs from insiders. Insiders purchased 1,261,818 shares during that period but sold 2,261,514.

In the most recent transaction, Rosenthal Arnon sold 23,831 shares of ALEC for 5.56 per share on Dec 04. After the transaction, the Chief Executive Officer now owns 2,019,217 company shares. In a previous transaction on Dec 04, Kenkare-Mitra Sara sold 12,519 shares at 5.56 per share. ALEC shares that President and Head of R&D owns now total 329,016.

Among the insiders who sold shares, Romano Gary disposed of 5,035 shares on Dec 04 at a per-share price of $5.56. This resulted in the Chief Medical Officer holding 202,314 shares of ALEC after the transaction. In another insider transaction, GRASSO MARC sold 4,574 shares at $5.56 per share on Dec 04. Company shares held by the Chief Financial Officer now total 150,673.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for ALEC in the last 3 months, the mean price target is $14.22 with high estimates of $41.00 and low estimates of $4.00. In terms of 52-week highs and lows, ALEC has a high of $9.86 and a low of $3.66.

As of this writing, ALEC has an earnings estimate of -$0.78 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.65 per share and a lower estimate of -$0.9. The company reported an EPS of $0.02 in the last quarter, which was 102.40% higher than expectations of -$0.82.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ALEC’s latest balance sheet shows that the firm has $735.25M in Cash & Short Term Investments as of fiscal 2021. There were $47.60M in debt and $139.56M in liabilities at the time. Its Book Value Per Share was $1.93, while its Total Shareholder’s Equity was $300.72M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALEC is Buy with a score of 4.33.

Most Popular

Related Posts